C 21 H 25 NO5, monoclinic, P21/n (no. 14) a = 10.4501(19) Å,
and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
The title compound was synthesized according to a reported procedure [5] . A mixture of 5,5-dimethyl-cyclohexane-1,3-dione (10 mmol), 3-methoxy-4-hydroxy-benzaldehyde (10 mmol), and 3-amino-2-butenoic acid methyl ester (10 mmol) in ethanol (100 mL) was refluxed for 2-3 h and then cooled to room temperature. After filtering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under a vacuum.
Experimental details
Hydrogen atoms were placed in calculated positions and were included in the refinement in the riding model approximation, with U iso (H) set to 1.2Ueq(C, N) and 1.5Ueq for methyl groups.
Discussion
Several derivatives of 4-arylpolyhydroquinoline are endowed with different types of biological activities [1] . It has been reported that some 4-arylpolyhydroquinoline derivatives exhibit antimicrobial activity, growth stimulating effects, antifungal and plant growth regulation effects, antitumor activity, central nervous system (CNS) activity and hypotensive effect [2, 3] . Moreover, some 4-arylpolyhydroquinoline derivatives are well known for antihistaminic activity, platelet antiaggregating activity and local anaesthetic activity, antiallergenic effect, antidepressant effect and as antiproliferation agents [4] . In the crystal structure of the title compound, the sixmembered ring containing nitrogen atom shows a folding angle of 21.5°between the planes intersecting C9-C12-N1-C14-C15 and C12 -N1C14. The folding of the adjacent hexenone moiety shows a folding angle of 47°between the enone moiety (C17-C16-C15-C14-C19) and the aliphatic part (C19-C18-C17) of the ring (cf. see the figure) . All geometric parameters are in the expected ranges.
